Traditional serrated adenoma: An update

Human Pathology

Volumn 46, Issue 7, 2015, Pages 933-938

  Bettington, Mark L ^a   Chetty, Runjan ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

BRAF; CIMP; KRAS; Serrated polyp; Traditional serrated adenoma

Indexed keywords

B RAF KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; K RAS PROTEIN; MISMATCH REPAIR PROTEIN; PROTEIN P53; WNT PROTEIN; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN; TP53 PROTEIN, HUMAN; TUMOR MARKER;

ABERRANT CRYPT FOCUS; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CHROMOENDOSCOPY; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; COLORECTAL POLYP; CYTOLOGY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ECTOPIC CRYPT FOCI; GASTROINTESTINAL DYSPLASIA; GASTROINTESTINAL ENDOSCOPY; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; PRACTICE GUIDELINE; PROTEIN FUNCTION; RECTUM ADENOMA; RISK FACTOR; TRADITIONAL SERRATED ADENOMA; WNT SIGNALING PATHWAY; ADENOMATOUS POLYP; BIOPSY; CLASSIFICATION; COLON POLYP; COLONOSCOPY; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROGNOSIS; SIGNAL TRANSDUCTION;

ADENOMATOUS POLYPS; BIOMARKERS, TUMOR; BIOPSY; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84931003722     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.04.002     Document Type: Article

References (33)

1. S.J. Urbanski, A.E. Kossakowski, N. Marcon, and W.R. Bruce Mixed hyperplastic adenomatous polyps-an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp Am J Surg Pathol 8 1984 551 554
2. T.A. Longacre, and C.M. Fenoglio-Preiser Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia Am J Surg Pathol 14 1990 524 537
3. E. Torlakovic, E. Skovlund, D.C. Snover, G. Torlakovic, and J.M. Nesland Morphologic reappraisal of serrated colorectal polyps Am J Surg Pathol 27 2003 65 81
4. E.E. Torlakovic, J.D. Gomez, and D.K. Driman Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA) Am J Surg Pathol 32 2008 21 29
5. F.T. Bosman, F. Carneiro, H.T. Hruban, and N.D. Theise World Health Organization WHO Classification of Tumours of the Digestive System 4th ed. 2010 International Agency for Research on Cancer Lyon, France
6. M.L. Bettington, N.I. Walker, and C. Rosty A clinicopathological and molecular analysis of 200 traditional serrated adenomas Mod Pathol 28 2015 414 427
7. B. Fu, S. Yachida, R. Morgan, Y. Zhong, E.A. Montgomery, and C.A. Iacobuzio-Donahue Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon Am J Clin Pathol 138 2012 356 366
8. M.J. Kim, E.J. Lee, and J.P. Suh Traditional serrated adenoma of the colorectum: clinicopathologic implications and endoscopic findings of the precursor lesions Am J Clin Pathol 140 2013 898 911
9. K.M. Kim, E.J. Lee, Y.H. Kim, D.K. Chang, and R.D. Odze KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype Am J Surg Pathol 34 2010 667 675
10. M. Fang, J. Ou, L. Hutchinson, and M.R. Green The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG island methylator phenotype Mol Cell 55 2014 904 915
11. R.W. Serra, M. Fang, S.M. Park, L. Hutchinson, and M.R. Green A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype eLife 3 2014 e02313 [1-22]
12. J.H. Tsai, J.Y. Liau, and Y.L. Lin Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis Mod Pathol 27 2014 1375 1385
13. M. Bettington, N. Walker, and C. Rosty Critical appraisal of the diagnosis of the sessile serrated adenoma Am J Surg Pathol 38 2014 158 166
14. T. Higuchi, K. Sugihara, and J.R. Jass Demographic and pathological characteristics of serrated polyps of colorectum Histopathology 47 2005 32 40
15. K.J. Spring, Z.Z. Zhao, and R. Karamatic High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy Gastroenterology 131 2006 1400 1407
16. H.O. Wiland IV, B. Shadrach, and D. Allende Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum Am J Surg Pathol 38 2014 1290 1297
17. S. Hasegawa, K. Mitsuyama, and H. Kawano Endoscopic discrimination of sessile serrated adenomas from other serrated lesions Oncol Lett 2 2010 785 789
18. S. Oka, S. Tanaka, and T. Hiyama Clinicopathologic and endoscopic features of colorectal serrated adenoma: differences between polypoid and superficial types Gastrointest Endosc 59 2004 213 219
19. D.A. Lieberman, D.K. Rex, S.J. Winawer, F.M. Giardiello, D.A. Johnson, and T.R. Levin Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer Gastroenterology 143 2012 844 857
20. M. Bettington, N. Walker, A. Clouston, I. Brown, B. Leggett, and V. Whitehall The serrated pathway to colorectal carcinoma: current concepts and challenges Histopathology 62 2013 367 386
21. S. Hafezi-Bakhtiari, L.M. Wang, R. Colling, S. Serra, and R. Chetty Histological overlap between colorectal villous/tubulovillous and traditional serrated adenomas Histopathology 66 2014 308 313
22. R. Chetty, S. Hafezi-Bakhtiari, S. Serra, R. Colling, and L.M. Wang Traditional serrated adenomas (TSAs) admixed with other serrated (so-called precursor) polyps and conventional adenomas: a frequent occurrence J Clin Pathol 68 2015 270 273
23. H. Iino, J.R. Jass, and L.A. Simms DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol 52 1999 5 9
24. E.J. Lee, C. Choi, and C.K. Park Tracing origin of serrated adenomas with BRAF and KRAS mutations Virchows Arch 447 2005 597 602
25. D.K. Rex, D.J. Ahnen, and J.A. Baron Serrated lesions of the colorectum: review and recommendations from an expert panel Am J Gastroenterol 107 2012 1315 1329 [quiz 1314, 1330]
26. R.K. Yantiss, K.Y. Oh, Y.T. Chen, M. Redston, and R.D. Odze Filiform serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases Am J Surg Pathol 31 2007 1238 1245
27. S.Y. Ha, S.M. Lee, and E.J. Lee Filiform serrated adenoma is an unusual, less aggressive variant of traditional serrated adenoma Pathology 44 2012 18 23
28. Y.H. Kim, S. Kakar, L. Cun, G. Deng, and Y.S. Kim Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps Int J Cancer 123 2008 2587 2593
29. M.J. O'Brien, S. Yang, and C. Mack Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points Am J Surg Pathol 30 2006 1491 1501
30. W.S. Samowitz, C. Sweeney, and J. Herrick Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers Cancer Res 65 2005 6063 6069
31. R.K. Pai, P. Jayachandran, and A.C. Koong BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features Am J Surg Pathol 36 2012 744 752
32. A.I. Phipps, P.J. Limburg, and J.A. Baron Association between molecular subtypes of colorectal cancer and patient survival Gastroenterology 148 2015 77 87
33. F.A. Sinicrope, Q. Shi, and T.C. Smyrk Molecular markers identify subtypes of stage iii colon cancer associated with patient outcomes Gastroenterology 148 2015 88 99